IT
Intellia Therapeutics Inc
🇺🇸XNAS.NTLAUnited StatesHealthcare
$11.49USDup +0.14 (+1.23%)ClosedDelayed7:42 AM
Price$11.49+0.14 (+1.23%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US45826J1051
- CUSIP
- 45826J105
Company
- Employees
- 377
- Headquarters
- Cambridge, United States
- Website
- https://www.intelliatx.com
- CEO
- Dr. John M. Leonard M.D.
Market
- Shares outstanding
- 140.1M
- Market cap
- $1.61B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $1.61B
- EPS LTM
- -$2.85calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -4.03calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $59.51M+12.58%up year on year
- Net income
- -$399.98M+16.71%up year on year
- Gross margin
- -46.48%+90.32%up year on year
- Free cash flow
- -$466.11M-10.5%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.